Tanfac Industries Ltd
Incorporated in 1972, Tanfac Industries Ltd is amongst the leading producers of Hydrofluoric Acid and its derivatives.
- Market Cap ₹ 2,830 Cr.
- Current Price ₹ 2,837
- High / Low ₹ 3,970 / 1,876
- Stock P/E 32.1
- Book Value ₹ 313
- Dividend Yield 0.24 %
- ROCE 41.6 %
- ROE 32.5 %
- Face Value ₹ 10.0
Pros
- Company is expected to give good quarter
- Company has delivered good profit growth of 39.0% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 30.3%
Cons
- Stock is trading at 9.18 times its book value
- Working capital days have increased from 66.1 days to 93.2 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Chemicals Industry: Chemicals
Part of BSE Commodities BSE SmallCap BSE Allcap
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
117 | 120 | 133 | 126 | 162 | 222 | 165 | 148 | 320 | 375 | 378 | 557 | |
106 | 112 | 125 | 112 | 141 | 169 | 138 | 115 | 244 | 299 | 306 | 428 | |
Operating Profit | 11 | 8 | 9 | 14 | 21 | 53 | 27 | 33 | 76 | 76 | 72 | 129 |
OPM % | 10% | 7% | 7% | 11% | 13% | 24% | 16% | 22% | 24% | 20% | 19% | 23% |
0 | 1 | 4 | 1 | 0 | 1 | 1 | 1 | 3 | 8 | 7 | 3 | |
Interest | 10 | 10 | 8 | 7 | 7 | 4 | 2 | 1 | 2 | 2 | 2 | 3 |
Depreciation | 7 | 6 | 5 | 5 | 5 | 8 | 5 | 8 | 6 | 6 | 7 | 10 |
Profit before tax | -6 | -7 | 0 | 3 | 10 | 42 | 22 | 25 | 72 | 75 | 70 | 119 |
Tax % | -45% | -20% | -8% | 0% | 1% | 14% | 22% | 30% | 26% | 26% | 25% | 26% |
-3 | -5 | 0 | 3 | 10 | 36 | 17 | 17 | 53 | 56 | 52 | 88 | |
EPS in Rs | -3.04 | -5.30 | 0.40 | 3.30 | 9.70 | 36.06 | 17.01 | 17.51 | 53.41 | 56.27 | 52.61 | 88.37 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 17% | 12% | 13% | 10% |
Compounded Sales Growth | |
---|---|
10 Years: | 17% |
5 Years: | 28% |
3 Years: | 20% |
TTM: | 47% |
Compounded Profit Growth | |
---|---|
10 Years: | 33% |
5 Years: | 39% |
3 Years: | 19% |
TTM: | 76% |
Stock Price CAGR | |
---|---|
10 Years: | 61% |
5 Years: | 85% |
3 Years: | 69% |
1 Year: | 24% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 32% |
3 Years: | 30% |
Last Year: | 33% |
Balance Sheet
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
Reserves | -5 | -10 | -10 | -7 | 3 | 38 | 55 | 73 | 124 | 174 | 220 | 302 |
70 | 69 | 61 | 54 | 43 | 12 | 0 | 0 | 0 | 0 | 0 | 41 | |
31 | 26 | 30 | 20 | 29 | 48 | 24 | 37 | 49 | 68 | 71 | 73 | |
Total Liabilities | 106 | 95 | 91 | 77 | 86 | 107 | 89 | 120 | 182 | 252 | 301 | 426 |
59 | 53 | 49 | 45 | 41 | 34 | 33 | 40 | 40 | 55 | 61 | 168 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 1 | 6 | 3 | 12 | 6 | 29 | 8 |
Investments | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 23 | 42 | 67 | 67 | 9 |
46 | 42 | 42 | 31 | 44 | 71 | 49 | 55 | 88 | 124 | 145 | 242 | |
Total Assets | 106 | 95 | 91 | 77 | 86 | 107 | 89 | 120 | 182 | 252 | 301 | 426 |
Cash Flows
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
19 | 9 | 16 | 16 | 17 | 37 | 22 | 37 | 44 | 43 | 34 | 33 | |
-0 | 0 | -1 | -1 | -1 | -3 | -9 | -34 | -35 | -40 | -30 | -42 | |
-19 | -10 | -15 | -15 | -17 | -34 | -12 | -1 | -5 | -6 | -7 | 32 | |
Net Cash Flow | -0 | -0 | -0 | 0 | -0 | 0 | -0 | 2 | 5 | -3 | -3 | 23 |
Ratios
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 56 | 52 | 54 | 46 | 44 | 38 | 40 | 40 | 28 | 49 | 59 | 65 |
Inventory Days | 136 | 106 | 82 | 66 | 75 | 107 | 75 | 134 | 91 | 89 | 100 | 108 |
Days Payable | 113 | 89 | 97 | 69 | 74 | 90 | 47 | 142 | 76 | 78 | 77 | 47 |
Cash Conversion Cycle | 80 | 68 | 39 | 42 | 45 | 54 | 67 | 31 | 43 | 60 | 82 | 126 |
Working Capital Days | 38 | 40 | 30 | 29 | 30 | 46 | 66 | 36 | 33 | 46 | 59 | 93 |
ROCE % | 6% | 4% | 7% | 18% | 29% | 78% | 37% | 35% | 67% | 48% | 33% | 42% |
Documents
Announcements
-
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
1d - TANFAC confirms non-applicability as 'Large Corporate' under SEBI for FY ended March 31, 2025.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
28 Apr - Tanfac reports record FY25 revenue ₹560 Cr, EBITDA ₹132 Cr, PAT ₹88 Cr post new HF plant commissioning.
-
Board Meeting Outcome for Audited Financial Results For The Quarter And Year Ended March 31, 2025 And Recommendation Of Dividend
28 Apr - Approved FY25 audited results; recommended Rs.9/share dividend subject to shareholder approval.
-
Board Meeting Intimation for Considering The Audited Financial Results For The Quarter And Year Ended March 31, 2025 And Recommendation Of Dividend
21 Apr - Board meeting on April 28 to approve FY25 results and recommend dividend; trading window closed April 1-30.
-
Announcement under Regulation 30 (LODR)-Demise
19 Apr - Managing Director K. Sendhil Naathan (DIN:08850046) passed away on April 18, 2025
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Product Portfolio
The company manufactures inorganic fluorine-based chemicals like Anhydrous Hydrofluoric acid, Sulphuric Acid, Oleum, Aluminum Fluoride, Potassium Fluoride, Potassium Bifluoride, Boron Trifluoride Complexes, Calcium Sulphate (Gypsum), IsoButyl Acetophenone, Acetic Acid, Peracetic Acid and Poly Aluminum Chloride, etc. [1]